These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25605418)

  • 21. Is urinary tract cytology still useful for diagnosis of bladder carcinomas? A large series of 592 bladder washings using a five-category classification of different cytological diagnoses.
    Garbar C; Mascaux C; Wespes E
    Cytopathology; 2007 Apr; 18(2):79-83. PubMed ID: 17397491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artificial neural network model to distinguish pleomorphic adenoma from adenoid cystic carcinoma on fine needle aspiration cytology.
    Kapatia G; Dey P; Saikia UN
    Cytopathology; 2020 Sep; 31(5):445-450. PubMed ID: 31693259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
    Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
    Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative evaluation of the nuclear matrix protein, fibronectin, urinary bladder cancer antigen and voided urine cytology in the detection of bladder tumors.
    Eissa S; Swellam M; Sadek M; Mourad MS; El Ahmady O; Khalifa A
    J Urol; 2002 Aug; 168(2):465-9. PubMed ID: 12131289
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A deep learning system to diagnose the malignant potential of urothelial carcinoma cells in cytology specimens.
    Nojima S; Terayama K; Shimoura S; Hijiki S; Nonomura N; Morii E; Okuno Y; Fujita K
    Cancer Cytopathol; 2021 Dec; 129(12):984-995. PubMed ID: 33979039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimens.
    Cheng L; Reiter RE; Jin Y; Sharon H; Wieder J; Lane TF; Rao J
    J Urol; 2003 Jun; 169(6):2094-100. PubMed ID: 12771726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urinary cytology for the detection of urothelial carcinoma of the bladder--a flawed adjunct to cystoscopy?
    Bolenz C; West AM; Ortiz N; Kabbani W; Lotan Y
    Urol Oncol; 2013 Apr; 31(3):366-71. PubMed ID: 21414815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multigene urine test for the detection and stratification of bladder cancer in patients presenting with hematuria.
    O'Sullivan P; Sharples K; Dalphin M; Davidson P; Gilling P; Cambridge L; Harvey J; Toro T; Giles N; Luxmanan C; Alves CF; Yoon HS; Hinder V; Masters J; Kennedy-Smith A; Beaven T; Guilford PJ
    J Urol; 2012 Sep; 188(3):741-7. PubMed ID: 22818138
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison.
    Hautmann S; Toma M; Lorenzo Gomez MF; Friedrich MG; Jaekel T; Michl U; Schroeder GL; Huland H; Juenemann KP; Lokeshwar VB
    Eur Urol; 2004 Oct; 46(4):466-71. PubMed ID: 15363562
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urine cytology in the follow-up of patients with transitional cell carcinoma of the urinary bladder: is that enough as a single method?
    Raica M; Miclea F; Ioiart I; Minciu R; Drăgan P
    Rom J Morphol Embryol; 1998; 44(1-4):173-8. PubMed ID: 15678859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Digitized microscopy in the diagnosis of bladder cancer: analysis of >3000 cases during a 7-month period.
    Marganski WA; El-Sirgany Costa V; Kilpatrick MW; Tafas T; Yim J; Matthews M
    Cancer Cytopathol; 2011 Aug; 119(4):279-89. PubMed ID: 21413160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Could nuclear matrix protein 22 (NMP22) play a role with urine cytology in screening for bladder cancer?--experience at Kuwait University.
    Kapila K; Kehinde EO; Anim JT; Mojiminiyi OA; Vinsu A; George SS; Al-Maghrebi M; Al-Mulla F
    Cytopathology; 2008 Dec; 19(6):369-74. PubMed ID: 18631356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p16(INK4a) /Ki-67 dual labelling as a marker for the presence of high-grade cancer cells or disease progression in urinary cytopathology.
    Piaton E; Advenier AS; Carré C; Decaussin-Petrucci M; Mege-Lechevallier F; Ruffion A
    Cytopathology; 2013 Oct; 24(5):327-34. PubMed ID: 23003335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytohistological study of urinary bladder neoplasms.
    Misra V; Gupta SC; Tandon SP; Gupta AK; Sircar S
    Indian J Pathol Microbiol; 2000 Jul; 43(3):303-9. PubMed ID: 11218677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Value of fluorescence in situ hybridization of urine exfoliative cells in diagnosis of urinary bladder neoplasms].
    Chen N; Gong J; Zeng H; Wei Q; Zhu YC; Chen M; Zhou Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2011 Jan; 42(1):109-13. PubMed ID: 21355314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic tests in urology: urine cytology.
    Lavallée LT; Fergusson D; Dahm P; Scales CD; Witiuk K; Breau RH
    BJU Int; 2012 Dec; 110(11 Pt C):E789-91. PubMed ID: 23106855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dilemma of suspicious urine cytology in patients being followed for bladder cancer.
    Raitanen MP; Aine R; Kylmälä T; Kallio J; Liukkonen T; Tammela T;
    Ann Chir Gynaecol; 2001; 90(4):256-9. PubMed ID: 11820413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Urinary NMP22 BladderChek test in the diagnosis of superficial bladder cancer.
    Moonen PM; Kiemeney LA; Witjes JA
    Eur Urol; 2005 Dec; 48(6):951-6; discussion 956. PubMed ID: 16257108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary survivin mRNA expression and urinary nuclear matrix protein 22 BladderChek® and urine cytology in the detection of transitional cell carcinoma of the bladder.
    Al-Maghrebi M; Kehinde EO; Kapila K; Anim JT
    Med Princ Pract; 2012; 21(3):295-7. PubMed ID: 22236881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.
    Degtyar P; Neulander E; Zirkin H; Yusim I; Douvdevani A; Mermershtain W; Kaneti J; Manor E
    Urology; 2004 Feb; 63(2):398-401. PubMed ID: 14972510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.